NET PROFIT (x1000 EUR)
EMPLOYEES
Recipharm Stockholm AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
1
|
285
|
560 |
Earnings before taxes |
46
|
-77
|
1,550 |
EBITDA |
-33
|
23
|
1,855 |
Total assets |
2,165
|
2,127
|
10,586 |
Current assets |
2,165
|
2,065
|
10,439 |
Current liabilities |
3
|
175
|
8,213 |
Equity capital |
2,162
|
1,911
|
2,119 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
0
![]() |
0
|
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.9%
|
89.8%
|
20.0% |
Turnover per employee | 0 | ||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
2.2%
|
9.8%
|
19.9% |
Current ratio |
72166.7%
|
1180.0%
|
127.1% |
Return on equity (ROE) |
2.1%
|
-4.0%
|
73.1% |
Change turnover |
0
![]() |
0
|
-21,464 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
-15
|
-119 |
Chg. No. of employees % |
-100%
|
-89% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.